Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Integra Lifesciences Sees Q4 Adj EPS $0.79-$0.84 vs $0.92 Est; Sees Sales $420.000M-$440.000M vs $456.197M Est

Author: Benzinga Newsdesk | October 30, 2025 05:02am
Integra Lifesciences (NASDAQ:IART) is looking for Q4 Adj EPS of $0.79-$0.84 vs $0.92 analyst estimate. sees sales of $420.000 million-$440.000 million vs $456.197 million analyst estimate.

Posted In: IART


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist